[Basdowian ophthalmic diseases. Pathogenic role of L-triiodothyronine and of LATS. Therapeutic role of L-thyroxine, of d-thyroxine and of corticoids].
D013956:Antithyroid Agents / Q000627:therapeutic use*; D001623:Betamethasone / Q000627:therapeutic use*; D003918:Dextrothyroxine / Q000627:therapeutic use*; D005128:Eye Diseases / Q000188:drug therapy / Q000209:etiology*; D006111:Graves Disease / Q000150:complications*; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications*; D008135:Long-Acting Thyroid Stimulator / Q000009:adverse effects*; D013974:Thyroxine / Q000627:therapeutic use*; D014284:Triiodothyronine / Q000009:adverse effects*
D013956:Antithyroid Agents; D014284:Triiodothyronine; D003918:Dextrothyroxine; D008135:Long-Acting Thyroid Stimulator; D001623:Betamethasone; D013974:Thyroxine
Les ophtalmopathies basedowiennes. Rôle pathogénique de la L-triiodothyronine et du LATS. Rôle thérapeutique de la L-thyroxine, de la d-thyroxine et des corticoïdes.